Latest Breaking News On - Investigator initiated phase - Page 1 : comparemela.com
Let’s start up with the current stock price of Onconova Therapeutics Inc. (ONTX), which is $0.66 to be very precise. The Stock rose vividly during the last session to $0.73 after opening rate of $0.7205 while the lowest price it went was recorded $0.6543 before closing at $0.72.
Recently in News on April 22, 2021, Onconova Announces First Patient Dosed in Investigator-Initiated Phase 2 Study of Rigosertib in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma. Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced today that the first patient has been dosed in an investigator-initiated Phase 2 study to assess the efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa (RDEB)-associated locally advanced/metastatic squamous cell carcinoma (SCC). The patient was dosed at the EB House Austria, a center
Austria
United-kingdom
Salzburg
Onconova-therapeutics-inc
University-hospital-salzburg
Nasdaq
Onconova-therapeutics
Onconova-announces-first-patient-dosed
Investigator-initiated-phase
Backdoor-way-to-profit-from-today
Crypto-bull-market